Centrexion Therapeutics Corporation announced that it has received funding from Lilly Ventures Management Company, LLC, Exome Asset Management LLC, Solar Capital Partners, LLC
Centrexion Therapeutics Corporation announced that it has received a round of funding on October 29, 2020. The transaction include participation in convertible security investments from new investors Lilly Ventures Management Company, LLC and Exome Asset Management LLC and in debt from existing investor Solar Capital Partners, LLC.